Literature DB >> 12540948

Leukocyte trans-endothelial migration: JAMs add new pieces to the puzzle.

Triantafyllos Chavakis1, Klaus T Preissner, Sentot Santoso.   

Abstract

The molecular details of leukocyte transmigration through the endothelial barrier (also called diapedesis), which is the final step of leukocyte extravasation from the circulation to a given site of inflammation, are by far not well understood. The present review will focus on the different mechanisms potentially involved in leukocyte trans-endothelial migration. Both homophilic and heterophilic interactions between leukocyte and endothelial cell receptors will be covered, with a particular focus on the growing gene family of junctional adhesion molecules (JAM). Deciphering their mechanisms of interaction will also allow to unravel novel strategies for therapeutic intervention in inflammatory or atherothrombotic diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12540948

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  11 in total

1.  JAM-C is a component of desmosomes and a ligand for CD11b/CD18-mediated neutrophil transepithelial migration.

Authors:  Ke Zen; Brian A Babbin; Yuan Liu; John B Whelan; Asma Nusrat; Charles A Parkos
Journal:  Mol Biol Cell       Date:  2004-06-11       Impact factor: 4.138

2.  The extracellular adherence protein from Staphylococcus aureus inhibits neutrophil binding to endothelial cells.

Authors:  Axana Haggar; Cecilia Ehrnfelt; Jan Holgersson; Jan-Ingmar Flock
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

3.  The extracellular adherence protein (Eap) of Staphylococcus aureus inhibits wound healing by interfering with host defense and repair mechanisms.

Authors:  Athanasios N Athanasopoulos; Matina Economopoulou; Valeria V Orlova; Astrid Sobke; Darius Schneider; Holger Weber; Hellmut G Augustin; Sabine A Eming; Uwe Schubert; Thomas Linn; Peter P Nawroth; Muzaffar Hussain; Hans-Peter Hammes; Mathias Herrmann; Klaus T Preissner; Triantafyllos Chavakis
Journal:  Blood       Date:  2005-11-29       Impact factor: 22.113

Review 4.  Blood-Bile Barrier: Morphology, Regulation, and Pathophysiology.

Authors:  Tirthadipa Pradhan-Sundd; Satdarshan Pal Monga
Journal:  Gene Expr       Date:  2019-01-15

Review 5.  The immune system and cardiac repair.

Authors:  Nikolaos G Frangogiannis
Journal:  Pharmacol Res       Date:  2008-06-24       Impact factor: 7.658

6.  Genetic deletion of JAM-C reveals a role in myeloid progenitor generation.

Authors:  Asja Praetor; Jacqueline M McBride; Henry Chiu; Linda Rangell; Lorena Cabote; Wyne P Lee; James Cupp; Dimitry M Danilenko; Sherman Fong
Journal:  Blood       Date:  2008-12-24       Impact factor: 22.113

7.  Murine junctional adhesion molecules JAM-B and JAM-C mediate endothelial and stellate cell interactions during hepatic fibrosis.

Authors:  Edith Hintermann; Monika Bayer; Janine Ehser; Michel Aurrand-Lions; Josef M Pfeilschifter; Beat A Imhof; Urs Christen
Journal:  Cell Adh Migr       Date:  2016-04-25       Impact factor: 3.405

8.  Junctional adhesion molecule (JAM)-B supports lymphocyte rolling and adhesion through interaction with alpha4beta1 integrin.

Authors:  Ralf J Ludwig; Katja Hardt; Max Hatting; Roxana Bistrian; Sandra Diehl; Heinfried H Radeke; Maurizio Podda; Michael P Schön; Roland Kaufmann; Reinhard Henschler; Josef M Pfeilschifter; Sentot Santoso; Wolf-Henning Boehncke
Journal:  Immunology       Date:  2009-10       Impact factor: 7.397

9.  Chemotactic antiviral cytokines promote infectious apical entry of human adenovirus into polarized epithelial cells.

Authors:  Verena Lütschg; Karin Boucke; Silvio Hemmi; Urs F Greber
Journal:  Nat Commun       Date:  2011-07-12       Impact factor: 14.919

10.  The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment.

Authors:  Triantafyllos Chavakis; Angelika Bierhaus; Nadia Al-Fakhri; Darius Schneider; Steffen Witte; Thomas Linn; Mariko Nagashima; John Morser; Bernd Arnold; Klaus T Preissner; Peter P Nawroth
Journal:  J Exp Med       Date:  2003-11-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.